Health Care·June 4, 2026
BTIG Upgrades Medtronic (MDT) to Buy With $90 Target; UBS Cuts to $85
Split analyst calls on MDT: BTIG upgrades to Buy with a $90 target while UBS trims its target to $85 — here's what it means for MDT investors.
Medtronic plc (NYSE: MDT) Stock News & Analysis
Medtronic plc (NYSE: MDT) is a healthcare company, listed on the NYSE. Alpha Stocks Insight has published 4 articles on MDT since June 3, 2026, most recently "Medtronic (NYSE: MDT) Posts 13.7% Revenue Growth in Q1 FY2027, Raises Full-Year Guidance" on Tuesday, September 1, 2026. Coverage to date spans Earnings Report and Health Care, tracking MDT's earnings, analyst activity, and material corporate events. New coverage is added each trading day.
Price
$91.89
Today
-0.54%
Mkt Cap
$117.5B
P/E
22.6x
52W High
$106.33
52W Low
$73.31
Data via Finnhub · refreshes hourly · not financial advice
MDT Coverage -- 4 Articles
Earnings Report·Tuesday, September 1, 2026
Medtronic (NYSE: MDT) Posts 13.7% Revenue Growth in Q1 FY2027, Raises Full-Year Guidance
MDT beat adjusted EPS by $0.05 and delivered $9.76B in Q1 revenue, then raised its FY27 organic growth and EPS outlook — here's what drove it.
4 min readRead article
Health Care·June 4, 2026
Medtronic (MDT) Files FDA 510(k) Applications for Hugo Robotic Surgery System
Medtronic submitted 510(k) applications covering general surgery indications for its Hugo RAS system — here's what the FDA filing means for MDT investors.
Earnings Report·June 3, 2026
Medtronic (MDT) Posts Strongest Top-Line Quarter in a Decade in Q4 FY2026
Medtronic beat Q4 FY2026 EPS and revenue estimates, with executives calling it the strongest top-line quarter in 10 years — here's what it means for MDT investors.
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.